Found: 9
Select item for more details and to access through your institution.
A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 6895, doi. 10.3390/ijms23136895
- By:
- Publication type:
- Article
ASO Visual Abstract: Five-Year Oncologic Outcome and Surgical Completeness of Transoral Robotic Thyroidectomy for Papillary Thyroid Carcinoma: Comparison with Conventional Transcervical Thyroidectomy Using Propensity Score-Matching.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Five-Year Oncologic Outcome and Surgical Completeness of Transoral Robotic Thyroidectomy for Papillary Thyroid Carcinoma: Comparison with Conventional Transcervical Thyroidectomy Using Propensity Score Matching.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 4, p. 2256, doi. 10.1245/s10434-022-13020-y
- By:
- Publication type:
- Article
Characterization of human cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (hCTLA4Ig) expressed in transgenic rice cell suspension cultures.
- Published in:
- Biotechnology Letters, 2006, v. 28, n. 24, p. 2039, doi. 10.1007/s10529-006-9191-7
- By:
- Publication type:
- Article
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920926796
- By:
- Publication type:
- Article
Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00571
- By:
- Publication type:
- Article
Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.
- Published in:
- Langenbeck's Archives of Surgery, 2021, v. 406, n. 4, p. 1223, doi. 10.1007/s00423-021-02189-7
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.715000
- By:
- Publication type:
- Article
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 222, doi. 10.1093/neuonc/noy105
- By:
- Publication type:
- Article